NEXT GENERATION INVESTMENT BANKING

Members network
Limited Mobile Version
Follow this company and never miss a research update
ORX

Orexo

Research update

Print

Orexo: Zubsolv Rx Data week 8, 2017

Zubsolv tablets showed a market share of 5.50% (5.54%), 4-week rolling average. The total number of Zubsolv tablets sold week 8 (7) reaching 308,626 (321,491). Zubsolv prescriptions (TRx) recorded a market share of 5.53% (5.57%), 4-week rolling average. Total number of prescriptions reaching 11,164 (11,599) during the week. The overall market (buprenorphine/naloxone) show-ed a y/y growth rate of 9.0% (9.4%) (4-week rolling average unit sales). TRx showed a y/y growth rate by 11.3% (11.5%) (4-week rolling average).

Download full report icon-download